| RF_ID |
Disease Name |
2ndClass |
3rdClass |
4thClass |
Species |
RF_Name |
Association |
Condition |
PMID |
| 1778 |
Alzheimer's Disease |
Medical methods |
Medicines |
Analgesic and anti-inflammatory drugs |
Human |
Muscle relaxant |
RF |
|
36641664 |
| 1775 |
Alzheimer's Disease |
Medical methods |
Medicines |
Analgesic and anti-inflammatory drugs |
Human |
Muscle relaxant |
RF |
|
36641664 |
| 1779 |
Alzheimer's Disease |
Medical methods |
Medicines |
Analgesic and anti-inflammatory drugs |
Human |
Muscle relaxant |
RF |
|
36641664 |
| 870 |
Alzheimer's Disease |
Medical methods |
Medicines |
Analgesic and anti-inflammatory drugs |
mice |
dexibuprofen (DXI) |
PF |
|
34294142 |
| 566 |
Alzheimer's Disease |
Medical methods |
Medicines |
Analgesic and anti-inflammatory drugs |
Human |
no chronic use of nonsteroidal anti-inflammatory drugs |
PF |
|
18446027 |
| 392 |
Alzheimer's Disease |
Medical methods |
Medicines |
Analgesic and anti-inflammatory drugs |
Human |
Non-aspirin NSAIDS |
PF |
|
33435977 |
| 373 |
Parkinson disease |
Medical methods |
Medicines |
Analgesic and anti-inflammatory drugs |
Human |
Non-aspirin NSAIDS |
PF |
|
33435977 |
| 735 |
Multiple System Atrophy |
Medical methods |
Medicines |
Analgesic and anti-inflammatory drugs |
Human |
use of non-aspirin nonsteroidal anti-inflammatory drugs (NSAIDs) |
PF |
|
31661696 |
| 645 |
Multiple System Atrophy |
Medical methods |
Medicines |
Analgesic and anti-inflammatory drugs |
Human |
use of non-aspirin nonsteroidal anti-inflammatory drugs (NSAIDs) |
PF |
Cumulative doses were used to divide observations into tertiles creating 3 groups of equal size (T1–3) based on the consumption in DDDs with T1 representing the group with the lowest use and T3 the highest. |
31661696 |
| 766 |
Multiple System Atrophy |
Medical methods |
Medicines |
Analgesic and anti-inflammatory drugs |
Human |
use of non-aspirin nonsteroidal anti-inflammatory drugs (NSAIDs) |
PF |
Cumulative doses were used to divide observations into tertiles creating 3 groups of equal size (T1–3) based on the consumption in defined daily dose(DDD) with T1 representing the group with the lowest use and T3 the highest. |
31661696 |
| 361 |
Progressive Supranuclear Palsy |
Medical methods |
Medicines |
Analgesic and anti-inflammatory drugs |
Human |
Non-steroidal anti-inflammatory drug (except
aspirin) |
Not Related |
|
19864660 |
| 1125 |
Multiple System Atrophy |
Medical methods |
Medicines |
Analgesic and anti-inflammatory drugs |
Human |
Aspirin |
PF |
|
18307243 |
| 539 |
Parkinson disease |
Medical methods |
Medicines |
Analgesic and anti-inflammatory drugs |
Human |
Aspirin |
PF |
|
34494887 |
| 360 |
Progressive Supranuclear Palsy |
Medical methods |
Medicines |
Analgesic and anti-inflammatory drugs |
Human |
Aspirin |
Not Related |
|
19864660 |
| 359 |
Progressive Supranuclear Palsy |
Medical methods |
Medicines |
Analgesic and anti-inflammatory drugs |
Human |
Anti-inflammatory agent |
Not Related |
|
19864660 |
| 1315 |
Parkinson disease |
Medical methods |
Medicines |
Analgesic and anti-inflammatory drugs |
Human |
Ibuprofen |
PF |
There was a dose-response relationship between tablets of ibuprofen taken per week and PD risk (p trend = 0.01). |
21368281 |
| 66 |
Alzheimer's Disease |
Medical methods |
Medicines |
Analgesic and anti-inflammatory drugs |
Human |
NSAIDs |
Not Related |
|
18519870 |
| 343 |
Parkinson disease |
Medical methods |
Medicines |
Analgesic and anti-inflammatory drugs |
Human |
NSAIDs |
Not Related |
|
17851257 |
| 67 |
Alzheimer's Disease |
Medical methods |
Medicines |
Analgesic and anti-inflammatory drugs |
Human |
NSAIDs |
Not Related |
|
10192221 |
